首页> 外文期刊>Urology >Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study.
【24h】

Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study.

机译:根治性肾结直肠癌切除术治疗上尿路尿路上皮癌后基于证据的性别相关结局:大型多中心研究的结果。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To assess the sex differences in the clinical and pathologic characteristics of upper tract urothelial carcinoma (UTUC) and to determine the effect on prognosis after radical nephroureterectomy (RNU) in a large multicenter series. METHODS: The records of 1363 patients who had undergone RNU were reviewed from the UTUC Collaboration database. The median follow-up was 47 months (range 0-250). The pathologic slides were re-evaluated by genitourinary pathologists unaware of the original findings from the slides and the clinical outcomes. The endpoints were freedom from tumor recurrence and disease-specific survival. RESULTS: The male-to-female ratio was 2.1:1. The women were older than the men at diagnosis (70 +/- 11 vs 68 +/- 11 years; P < .001). No significant sex-related differences were found in the presence of symptoms at presentation (P = .70), pathologic stage (P = .98), tumor grade (P = .28), tumor architecture (P = .27), presence of lymphovascular invasion (P = .42), presence of concomitant carcinoma in situ (P = .08), or the presence of lymph node metastases (P = .24). Recurrence developed in 379 patients (28%), and 313 patients (23%) died of their disease. Sex was not associated with disease recurrence (P = .07) or disease-specific survival (P = .13). An adjustment for the effects of the pathologic features did not change the lack of association of sex with the clinical outcomes. CONCLUSIONS: To our knowledge, this is the largest series analyzing the effect of sex on the outcomes after RNU. No difference was found in the clinicopathologic features or prognosis between women and men treated with RNU for UTUC. The results of this large, international series show that RNU provides durable local control and disease-specific survival for both men and women with UTUC.
机译:目的:评估在大型多中心研究中,上尿路尿路上皮癌(UTUC)的临床和病理特征的性别差异,并确定根治性肾切除术(RNU)对预后的影响。方法:从UTUC协作数据库中回顾了1363例行RNU的患者的记录。中位随访时间为47个月(范围0-250)。泌尿生殖系统病理学家对病理切片进行了重新评估,但并未意识到切片的原始发现和临床结果。终点是无肿瘤复发和疾病特异性生存。结果:男女之比为2.1:1。诊断时女性比男性大(70 +/- 11岁对68 +/- 11岁; P <.001)。在出现症状时(P = .70),病理分期(P = .98),肿瘤等级(P = .28),肿瘤结构(P = .27),存在,均未发现明显的性别相关差异。淋巴管浸润的发生率(P = 0.42),原位并发癌(P = .08)或淋巴结转移(P = .24)。 379名患者(28%)复发,其中313名患者(23%)死于疾病。性别与疾病复发(P = .07)或疾病特异性生存(P = .13)无关。对病理特征影响的调整并没有改变性别与临床结局之间缺乏联系。结论:据我们所知,这是分析性别对RNU术后结局影响的最大系列研究。 RNU UTUC治疗的男女在临床病理特征或预后方面均无差异。这个大型国际系列的结果表明,RNU为患有UTUC的男性和女性提供了持久的局部控制和特定疾病的生存。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号